natgillin/translations-raw huggingface dataset:
the risk-weighted exposure amounts of the mezzanine securitisation positions which are held by the originator credit institution in this securitisation do not exceed 50 % of the risk weighted exposure amounts of all mezzanine securitisation positions existing in this securitisation;
zneski tveganju prilagojenih izpostavljenosti vmesnih pozicij listinjenja, ki jih imajo kreditne institucije v vlogi originatorja v listinjenju, ne presegajo 50 % zneskov tveganju prilagojenih izpostavljenosti vseh obstoječih vmesnih pozicij listinjenja v zadevnem listinjenju;
For the purposes of point 2a, mezzanine securitisation positions means securitisation positions to which a risk weight lower than 1250 % applies and that are more junior than the most senior position in this securitisation and more junior than any securitisation positions in this securitisation to which:
Za namene točke 2a so vmesne pozicije listinjenja tiste pozicije listinjenja, za katere se uporablja utež tveganja, nižja od 1250 %, in ki so podrejene najbolj nadrejenim pozicijam v zadevnem listinjenju in vsem pozicijam, katerim se:
As an alternative to points 2a and 2b, significant credit risk may be considered to have been transferred if the competent authority is satisfied that a credit institution has policies and methodologies in place to ensure that a possible reduction of capital requirements that the originator achieves by the securitisation is justified by a commensurate transfer of credit risk to third parties.
Namesto točk 2a in 2b se lahko šteje, da je bil pomemben delež kreditnega tveganja prenesen, če se pristojni organ prepriča, da je kreditna institucija vzpostavila politike in metodologijo, ki zagotavljajo, da je originatorjevo morebitno zmanjšanje kapitalskih zahtev, doseženih z listinjenjem, utemeljeno s sorazmernim prenosom kreditnega tveganja na tretje osebe.
The competent authorities shall only be satisfied if the originator credit institution can demonstrate that such transfer of credit risk to third parties is also recognised for purposes of the credit institutions internal risk management and its internal capital allocation.
Pristojni organ se lahko prepriča le, če mu kreditna institucija v vlogi originatorja lahko dokaže, da je namen prenosa kreditnega tveganja na tretje osebe prav tako njeno notranje obvladovanje tveganja in notranje razporejanje kapitala.
In addition, the transfer shall comply with the following conditions:’;
Poleg tega mora biti prenos v skladu z naslednjimi pogoji:“.
Annex IX, Part 4, is amended as follows:
Del 4 Priloge IX se spremeni:
in point 13 the introductory phrase is replaced by the following:
V točki 13 se uvodni stavek nadomesti z naslednjim:
‘When the following conditions are met, to determine its exposure value a conversion figure of 50 % may be applied to the nominal amount of a liquidity facility:’;
„Če so izpolnjeni naslednji pogoji, se lahko za določitev vrednosti izpostavljenosti nominalnega zneska likvidnostnega posojila uporabi konverzijski koeficient 50 %:“.
points 2.4.2 and 14 are deleted;
Točki 2.4.2 in 14 se izbrišeta.
point 48 is deleted;
Točka 48 se izbriše.
points 3.5.1 and 56 are deleted;
Točki 3.5.1 in 56 se izbrišeta.
in Annex X, Part 2, point 1 is replaced by the following:
Točka 1 dela 2 Priloge X se nadomesti z naslednjim:
The capital requirement for operational risk shall be calculated as the three-year average of the yearly summations of the capital requirements across business lines referred to in Table 2.
Kapitalska zahteva za operativno tveganje se izračuna kot triletno povprečje letnih seštevkov kapitalskih zahtev po poslovnih področjih, navedenih v tabeli 2.
In any given year, negative capital requirements (resulting from negative gross income) in any business line may offset positive capital requirements in other business lines without limit.
V danem letu se lahko negativne kapitalske zahteve (izhajajoč iz negativnega bruto dohodka) iz katerega koli poslovnega področja brez omejitev izravnajo s pozitivnimi kapitalskimi zahtevami iz drugega poslovnega področja.
However, where the aggregate capital requirements across all business lines within a given year are negative, the input to the numerator for that year shall be zero.’;
Če pa so v danem letu skupne kapitalske zahteve iz vseh poslovnih področij negativne, je števec za to leto enak nič.“
Annex X, Part 3, is amended as follows:
Del 3 Priloge X se spremeni:
Credit institutions shall be able to map their historical internal loss data into the business lines defined in Part 2 and into the event types defined in Part 5, and to provide these data to competent authorities upon request.
Kreditne institucije morajo biti sposobne razporediti svoje pretekle notranje podatke o izgubi po poslovnih področjih, opredeljenih v delu 2, in po vrstah dogodkov, opredeljenih v delu 5, ter te podatke na zahtevo zagotoviti pristojnim organom.
Loss events which affect the entire institution may be allocated to an additional business line “corporate items” due to exceptional circumstances.
Dogodki izgube, ki vplivajo na celotno institucijo, se lahko zaradi izjemnih okoliščin razporedijo na dodatno poslovno področje „postavke podjetja“.
Such losses shall not be subject to the operational risk charge, as long as they continue to be treated as credit risk for the purposes of calculating minimum capital requirements.
Takšne izgube ne bodo predmet kapitalski zahtevi za operativno tveganje, dokler se bodo za namene izračuna minimalnih kapitalskih zahtev obravnavale v okviru kreditnega tveganja.
Operational risk losses that are related to market risks shall be included in the scope of the capital requirement for operational risk.’;
Izgube iz operativnega tveganja, ki so povezane s tržnimi tveganji, se vključijo v obseg kapitalske zahteve za operativno tveganje.“
point 29 is replaced by the following:
Točka 29 se nadomesti z naslednjim:
The capital alleviation from the recognition of insurances and other risk transfer mechanisms shall not exceed 20 % of the capital requirement for operational risk before the recognition of risk mitigation techniques.’;
Kapitalsko zmanjšanje, ki izhaja iz priznanja zavarovanja in drugih oblik prenosa tveganja, ne presega 20 % kapitalske zahteve za operativno tveganje pred priznanjem tehnik za zmanjševanje tveganja.“
in Annex XII, Part 2, point 10 the following points (d) and (e) are added:
Točki 10 dela 2 Priloge XII se dodata točki (d) in (e):
the highest, the lowest and the mean of the daily value-at-risk measures over the reporting period and the value-at-risk measure as per the end of the period;
najvišje, najnižje in povprečne dnevne tvegane vrednosti za obdobje, ki ga zajema poročilo, in tvegano vrednosti ob koncu obdobja;
a comparison of the daily end-of-day value-at-risk measures to the one-day changes of the portfolio’s value by the end of the subsequent business day together with an analysis of any important overshootings during the reporting period.’;
primerjavo dnevnih tveganih vrednosti z enodnevnimi spremembami vrednosti portfelja do konca naslednjega delovnega dne skupaj z analizo vsakršnih pomembnih preseganj v obdobju, ki ga zajema poročilo.“
In Annex XII, Part 3, point 3 is replaced by the following:
Točka 3 dela 3 Priloge XII se nadomesti z naslednjim:
The credit institutions using the approach set out in Article 105 for the calculation of their own funds requirements for operational risk shall disclose a description of the use of insurances and other risk transfer mechanisms for the purpose of mitigation of this risk.’
Kreditne institucije, ki uporabljajo pristop, določen v členu 105 za izračun zahtev po lastnih sredstvih za operativno tveganje, razkrijejo opis uporabe zavarovanja in drugih oblik prenosa tveganja za namene zmanjševanja tveganja.“
Member States shall adopt and publish, by 31 October 2010 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice najpozneje do 31. oktobra 2010 sprejmejo in objavijo zakone ter druge predpise, potrebne za uskladitev s to direktivo.
They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
Besedilo navedenih predpisov ter korelacijsko tabelo med navedenimi predpisi in to direktivo takoj posredujejo Komisiji.
They shall apply those provisions from 31 December 2010.
Te predpise začnejo uporabljati od 31. decembra 2010.
OJ L 110, 20.4.2001, p. 28.’
UL L 110, 20.4.2001, str. 28.“
Commission Directive 2009/84/EC
Direktiva Komisije 2009/84/ES
of 28 July 2009
z dne 28. julija 2009
That list includes sulfuryl fluoride.
Navedeni seznam vključuje sulfuril fluorid.
Commission Directive 2006/140/EC [3] included sulfuryl fluoride as an active substance in Annex I to Directive 98/8/EC for use in product-type 8, wood preservatives, as defined in Annex V to Directive 98/8/EC.
Na podlagi Direktive Komisije 2006/140/ES [3] je bil sulfuril fluorid kot aktivna snov vključen v Prilogo I k Direktivi 98/8/ES za uporabo v 8. vrsti izdelkov, pripravkih za zaščito lesa, kot je opredeljena v Prilogi V k Direktivi 98/8/ES.
Pursuant to Regulation (EC) No 1451/2007, sulfuryl fluoride has now been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 18, insecticides, as defined in Annex V to that Directive.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja sulfuril fluorida glede uporabe v 18. vrsti izdelkov, insekticidih, kot je opredeljena v Prilogi V k navedeni direktivi.
Sweden was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 19 June 2007 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Švedska, ki je bila imenovana za državo članico poročevalko, je 19. junija 2007 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 20 February 2009, in an assessment report.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile ugotovitve pregleda 20. februarja 2009 v Stalnem odboru za biocidne pripravke vključene v poročilo o oceni.
It appears from the examinations made that biocidal products used as insecticides and containing sulfuryl fluoride may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Preiskave so pokazale, da je za biocidne pripravke, ki se uporabljajo kot insekticidi in vsebujejo sulfuril fluorid, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include sulfuryl fluoride in Annex I, in order to ensure that in all Member States authorisations for biocidal products used as insecticides and containing sulfuryl fluoride can be granted, modified, or cancelled in accordance with Article 16(3) of Directive 98/8/EC.
Zato je primerno vključiti sulfuril fluorid v Prilogo I, da se v vseh državah članicah v skladu s členom 16(3) Direktive 98/8/ES zagotovi, da se izdajo, spremenijo ali razveljavijo dovoljenja za biocidne pripravke, ki se uporabljajo kot insekticidi in vsebujejo sulfuril fluorid.
In the light of the conclusions of the assessment report, it is appropriate to require that products containing sulfuryl fluoride and used as insecticides be authorised only for use by trained professionals in accordance with Article 10(2)(i)(e) of Directive 98/8/EC, and that specific risk mitigation measures are applied at product authorisation level to ensure the safety of operators and of bystanders.
Glede na ugotovitve poročila o oceni je primerno zahtevati, da se v skladu s členom 10(2)(i)(e) Direktive 98/8/ES pri izdaji dovoljenj za pripravke, ki vsebujejo sulfuril fluorid in se uporabljajo kot insekticidi, uporaba dovoli zgolj usposobljenim strokovnjakom in da se uporabijo posebni ukrepi za zmanjšanje tveganja, s čimer se zagotovi varnost delavcev/uporabnikov in drugih navzočih oseb.
In addition, it is appropriate to require continuous monitoring of sulfuryl fluoride in remote tropospheric air and to require results of such monitoring to be regularly reported to the Commission.
Poleg tega je primerno zahtevati, da se izvaja stalni nadzor sulfuril fluorida v oddaljenem troposferskem ozračju in da se rezultati takega nadzora redno poročajo Komisiji.
It is important that the provisions of this Directive be applied simultaneously in all the Member States in order to ensure equal treatment of biocidal products on the market containing the active substance sulfuryl fluoride and also to facilitate the proper operation of the biocidal products market in general.
Pomembno je, da se določbe te direktive uporabljajo hkrati v vseh državah članicah, da se zagotovi enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov sulfuril fluorid, na trgu in da se omogoči ustrezno delovanje trga biocidnih pripravkov na sploh.
A reasonable period should be allowed to elapse before an active substance is included in Annex I in order to permit Member States and the interested parties to prepare themselves to meet the new requirements entailed and to ensure that applicants who have prepared dossiers can benefit fully from the 10-year period of data protection, which, in accordance with Article 12(1)(c)(ii) of Directive 98/8/EC, starts from the date of inclusion.
Pred vključitvijo aktivne snovi v Prilogo I je treba zagotoviti ustrezno obdobje, ki bo omogočilo državam članicam in zainteresiranim stranem, da se pripravijo na izpolnjevanje novih zahtev, ter vlagateljem, ki so pripravili dokumentacijo, da lahko povsem izkoristijo desetletno obdobje za varstvo podatkov, ki se v skladu s členom 12(1)(c)(ii) Direktive 98/8/ES začne z dnem vključitve.
After inclusion, Member States should be allowed a reasonable period to implement Article 16(3) of Directive 98/8/EC, and in particular, to grant, modify or cancel authorisations of biocidal products in product-type 18 containing sulfuryl fluoride to ensure that they comply with Directive 98/8/EC.
Državam članicam je treba po vključitvi dati na voljo ustrezno obdobje za izvedbo člena 16(3) Direktive 98/8/ES in zlasti za izdajo, spremembo ali razveljavitev dovoljenj za biocidne pripravke v 18. vrsti izdelkov, ki vsebujejo sulfuril fluorid, da se zagotovi njihova skladnost z Direktivo 98/8/ES.
Member States shall adopt and publish, by 30 June 2010 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 30. junija 2010.
They shall apply those provisions from 1 July 2011.
Navedeni predpisi se uporabljajo od 1. julija 2011.
Done at Brussels, 28 July 2009.
V Bruslju, 28. julija 2009
The following is added to entry ‘No 1’ in Annex I to Directive 98/8/EC:
V Prilogo I k Direktivi 98/8/ES se vstavi naslednji vnos „št. 1“:
1 July 2011
julij 2011
30 June 2013
junij 2013
30 June 2021
junij 2021
Products shall only be sold to and used by professionals trained to use them.
Pripravki se lahko prodajajo le posebej usposobljenim strokovnjakom, ki ga edini lahko uporabljajo.
Appropriate measures to protect fumigators and bystanders during fumigation and venting of treated buildings or other enclosures must be taken.
Sprejeti je treba ustrezne ukrepe za zaščito zaplinjevalcev in drugih navzočih oseb med zaplinjevanjem in prezračevanjem zgradb in drugih zaprtih prostorov.
Labels and/or safety-data sheets of products shall indicate that, prior to fumigation of any enclosure, all food items must be removed.
Na oznakah in/ali varnostnih listih pripravkov je navedeno, da je treba pred zaplinjevanjem zaprtega prostora odstraniti vse prehrambene izdelke.
Concentrations of sulfuryl fluoride in remote tropospheric air are monitored.
Nadzorujejo se koncentracije sulfuril fluorida v oddaljenem troposferskem ozračju.
Member States shall also ensure that reports of the monitoring referred to in point (4) are transmitted by authorisation holders directly to the Commission every fifth year, starting at the latest five years after the authorisation.
Države članice tudi zagotovijo, da imetniki dovoljenj pošljejo poročila nadzora iz točke 4 neposredno Komisiji, in sicer vsakih pet let z začetkom najpozneje pet let po pridobitvi dovoljenja.
The limit of detection for the analysis shall be at least 0,5 ppt (equivalent to 2,1 ng sulfuryl fluoride/m3 of tropospheric air).’
Mejna vrednost odkritja za analizo je najmanj 0,5 ppt (kar ustreza 2,1 ng sulfuril fluorida/m3 troposferskega ozračja).“
Commission Directive 2009/85/EC
Direktiva Komisije 2009/85/ES
amending Directive 98/8/EC of the European Parliament and of the Council to include coumatetralyl as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev kumatetralila kot aktivne snovi v Prilogo I k Direktivi
That list includes coumatetralyl.
Navedeni seznam vključuje kumatetralil.
Pursuant to Regulation (EC) No 1451/2007, coumatetralyl has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 14, rodenticides, as defined in Annex V to Directive 98/8/EC.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja kumatetralila glede uporabe v 14. vrsti izdelkov, rodenticidih, kot so opredeljeni v Prilogi V k Direktivi 98/8/ES.
Denmark was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 29 September 2005 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Danska, ki je bila imenovana za državo članico poročevalko, je 29. septembra 2005 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 20 February 2009, in an assessment report.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile ugotovitve pregleda v Stalnem odboru za biocidne pripravke vključene 20. februarja 2009 v poročilo o oceni.
It appears from the examinations made that biocidal products used as rodenticides and containing coumatetralyl may be expected not to present a risk to humans except for accidental incidents with children.
Preiskave so pokazale, da je za biocidne pripravke, ki se uporabljajo kot rodenticidi in vsebujejo kumatetralil, mogoče pričakovati, da za ljudi ne pomenijo tveganja, razen pri naključnih incidentih z otroki.
A risk has been identified regarding non-target animals.
Ugotovljeno je bilo tveganje za neciljne živali.
However, coumatetralyl is for the time being considered essential for reasons of public health and hygiene.
Trenutno zaradi javnega zdravja in higiene kumatetralil velja za nujno potrebnega.
It is therefore justified to include coumatetralyl in Annex I, in order to ensure that in all Member States authorisations for biocidal products used as rodenticides and containing coumatetralyl can be granted, modified, or cancelled in accordance with Article 16(3) of Directive 98/8/EC.
Zato je upravičeno vključiti kumatetralil v Prilogo I, da se v vseh državah članicah v skladu s členom 16(3) Direktive 98/8/ES zagotovi, da se lahko izdajo, spremenijo ali razveljavijo dovoljenja za biocidne pripravke, ki se uporabljajo kot rodenticidi in vsebujejo kumatetralil.
In the light of the findings of the assessment report, it is appropriate to require that specific risk mitigation measures are applied at product authorisation level to products containing coumatetralyl and used as rodenticides.
Glede na ugotovitve poročila o oceni je primerno zahtevati, da se na ravni izdaje dovoljenja za pripravke, ki vsebujejo kumatetralil in se uporabljajo kot rodenticidi, uporabijo posebni ukrepi za zmanjšanje tveganja.
Such measures should be aimed at limiting the risk of primary and secondary exposure of humans and non-target animals.
Namen teh ukrepov je omejiti tveganje primarnega in sekundarnega izpostavljanja ljudi in neciljnih živali.
To this end, certain constraints such as the maximum concentration, the prohibition on marketing the active substance in products which are not ready to use and the use of aversive agents should be imposed across the board, while other conditions should be imposed by the Member States on a case-by-case basis.
Zato je treba uvesti nekatere splošne omejitve, kot na primer največjo koncentracijo, prepoved trženja aktivne snovi v pripravkih, ki niso že pripravljeni za uporabo, in uporabo averzivnih sredstev, druge pogoje pa bi morale za vsak primer posebej uvesti države članice.
In view of the identified risks, coumatetralyl should be included in Annex I for five years only and should be made subject to a comparative risk assessment in accordance with the second subparagraph of Article 10(5)(i) of Directive 98/8/EC before its inclusion in Annex I is renewed.
Zaradi ugotovljenih tveganj je treba kumatetralil vključiti v Prilogo I samo za pet let, potem pa ga je mogoče ponovno vključiti vanjo le, če se v skladu z drugim pododstavkom člena 10(5)(i) Direktive 98/8/ES zanj izvede primerjalna ocena tveganja.
It is important that the provisions of this Directive be applied simultaneously in all the Member States in order to ensure equal treatment of biocidal products on the market containing the active substance coumatetralyl and also to facilitate the proper operation of the biocidal products market in general.
Pomembno je, da se določbe te direktive uporabljajo hkrati v vseh državah članicah, tako da se zagotovi enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov kumatetralil, na trgu in da se omogoči ustrezno delovanje trga biocidnih pripravkov na splošno.
A reasonable period should be allowed to elapse before an active substance is included in Annex I in order to permit Member States and the interested parties to prepare themselves to meet the new requirements entailed and to ensure that applicants who have prepared dossiers can benefit fully from the 10-year period of data protection, which, in accordance with Article 12(1)(c)(ii) of Directive 98/8/EC, starts from the date of inclusion.
Pred vključitvijo aktivne snovi v Prilogo I je treba zagotoviti ustrezno obdobje, ki bo omogočilo državam članicam in zainteresiranim stranem, da se pripravijo na izpolnjevanje novih zahtev, ter prijaviteljem, ki so pripravili dokumentacijo, da lahko povsem izkoristijo desetletno obdobje za varstvo podatkov, ki se v skladu s členom 12(1)(c)(ii) Direktive 98/8/ES začne z dnem vključitve.
After inclusion, Member States should be allowed a reasonable period to implement Article 16(3) of Directive 98/8/EC, and in particular, to grant, modify or cancel authorisations of biocidal products in product-type 14 containing coumatetralyl to ensure that they comply with Directive 98/8/EC.
Državam članicam je treba po vključitvi zagotoviti ustrezno obdobje za izvedbo člena 16(3) Direktive 98/8/ES in zlasti za izdajo, spremembo ali razveljavitev dovoljenj za biocidne pripravke v 14. vrsti izdelkov, ki vsebujejo kumatetralil, da se zagotovi njihova skladnost z Direktivo 98/8/ES.
Directive 98/8/EC should therefore be amended accordingly.
Zato je treba Direktivo 98/8/ES ustrezno spremeniti.
Member States shall adopt and publish, by 30 June 2010 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, do najpozneje 30. junija 2010.
They shall apply those provisions from 1 July 2011.
Navedene predpise uporabljajo od 1. julija 2011 dalje.
When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication.
Ko države članice sprejmejo te predpise, se ti sklicujejo na to direktivo ali pa je sklic nanjo naveden skupaj z njimi ob njihovi uradni objavi.